Evidence map›Paper›PMID 27055018›Full record

ArticlePloS one2016

Generation and Characterization of an Immortalized Human Esophageal Myofibroblast Line.

Chao Niu, Uday Chauhan, Matthew Gargus, Anisa Shaker

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chao NiuDepartment of Medicine, Division of Gastroenterology and Hepatology, Keck School of Medicine of USC, Los Angeles, California, United States of America.
Uday ChauhanDepartment of Medicine, Division of Gastroenterology and Hepatology, Keck School of Medicine of USC, Los Angeles, California, United States of America.
Matthew GargusDepartment of Medicine, Division of Gastroenterology and Hepatology, Keck School of Medicine of USC, Los Angeles, California, United States of America.
Anisa ShakerDepartment of Medicine, Division of Gastroenterology and Hepatology, Keck School of Medicine of USC, Los Angeles, California, United States of America.
Keck Hospital of USC · US

Funding

USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KANEL, GARY · 1995 to 2020
$21.8M
EPIMORPHIN DELETION ALTERS STEM CELL NICHE MYOFIBROBLAST SECRETIONK08CA153036 · NCI · WASHINGTON UNIVERSITY · PI SHAKER, ANISA · 2011 to 2016
$806k
Epithelial-stromal cross-talk in esophageal inflammation and carcinogenesis.R03CA198692 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHAKER, ANISA · 2015 to 2016
$165k
NCI NIH HHS K08 CA153036NCI NIH HHS KO8CA153036NCI NIH HHS R03 CA198692NCI NIH HHS R03CA198692NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

Stromal cells with a myofibroblast phenotype present in the normal human esophagus are increased in individuals with gastro-esophageal reflux disease (GERD). We have previously demonstrated that myofibroblasts stimulated with acid and TLR4 agonists increase IL-6 and IL-8 secretion using primary cultures of myofibroblasts established from normal human esophagus. While primary cultures have the advantage of reflecting the in vivo environment, a short life span and unavoidable heterogeneity limits the usefulness of this model in larger scale in vitro cellular signaling studies. The major aim of this paper therefore was to generate a human esophageal myofibroblast line with an extended lifespan. In the work presented here we have generated and characterized an immortalized human esophageal myofibroblast line by transfection with a commercially available GFP-hTERT lentivirus. Immortalized human esophageal myofibroblasts demonstrate phenotypic, genotypic and functional similarity to primary cultures of esophageal myofibroblasts we have previously described. We found that immortalized esophageal myofibroblasts retain myofibroblast spindle-shaped morphology at low and high confluence beyond passage 80, and express α-SMA, vimentin, and CD90 myofibroblast markers. Immortalized human esophageal myofibroblasts also express the putative acid receptor TRPV1 and TLR4 and retain the functional capacity to respond to stimuli encountered in GERD with secretion of IL-6. Finally, immortalized human esophageal myofibroblasts also support the stratified growth of squamous esophageal epithelial cells in 3D organotypic cultures. This newly characterized immortalized human esophageal myofibroblast cell line can be used in future cellular signaling and co-culture studies.

Indexed as

Gastroesophageal RefluxBiomarkersBlotting, WesternCell Line, TransformedCells, CulturedCoculture TechniquesCytokinesEsophagusFluorescent Antibody TechniqueHumansImmunoenzyme TechniquesMyofibroblastsPhenotypeReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerBiomarkersCytokinesRNA, Messenger

Identifiers

PMID27055018
PMCPMC4824353
OpenAlexW2318968392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.